• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: adeno-associated virus serotype rh.10 encoding for the human PKP2 gene (AAVrh.10hPKP2)
Date Designated: 12/14/2023
Orphan Designation: Treatment of arrhythmogenic cardiomyopathy due to a PKP2 pathogenic variant
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
LEXEO Therapeutics, Inc.
345 Park Avenue South, 6th Floor
New York, New York 10010
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-